Agronomics
We invest in opportunities within the Life Science sector, concentrating on, but not limited to, environmentally friendly alternatives to the traditional production of meat and plant-based nutrition sources such as cellular agriculture, cellular aquaculture and the alternative protein space. We focus on investments that provide scalable and commercially viable opportunities.
London, United KingdomFounded 2019
Finance
Coverage
Featured In
Digest
Louis Dreyfus doubles canola crush capacity; Cargill Ventures resumes agrifoodtech deals; Fairlife hit by ransomware
Monitor
All G enters US market with low-iron lactoferrin via microbial fermentation (agfundernews.com)
Digest
Bunge opens $550M soy plant; EU bars Brazilian meat; cell-cultured products reach pets and courts
Monitor
FDA clears first microbial fermentation-derived animal protein for pet food (prnewswire.com)
Digest